Cargando…
Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review
In recent years increased attention is focussed on microorganisms inhabiting the digestive system that provides prophylactic and therapeutic benefits to the host. After Metchnikoff exposed the secret behind Bulgarian peasants' extended longevity, a graze to incorporate the responsible microbes...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836964/ https://www.ncbi.nlm.nih.gov/pubmed/33519144 http://dx.doi.org/10.1016/j.jksus.2020.101286 |
_version_ | 1783642860249153536 |
---|---|
author | Al-Ansari, Mysoon M. Sahlah, Samer A. AlHumaid, Lateefah Ranjit Singh, A.J. |
author_facet | Al-Ansari, Mysoon M. Sahlah, Samer A. AlHumaid, Lateefah Ranjit Singh, A.J. |
author_sort | Al-Ansari, Mysoon M. |
collection | PubMed |
description | In recent years increased attention is focussed on microorganisms inhabiting the digestive system that provides prophylactic and therapeutic benefits to the host. After Metchnikoff exposed the secret behind Bulgarian peasants' extended longevity, a graze to incorporate the responsible microbes in functional food emerged. Then interest towards microbe-rich food went to the vegetative phase for some time, but now a renaissance to engage these wonder microbes in the healthcare sector is increasing. With a new definition, probiotics, these good microbes have been widely applied in different types of products, either as pharmaceuticals, nutritional supplements, or foods. Probiotics, a significant source in functional dairy products, claims diverse roles such as improving intestinal tract health, enhancing the immune system, synthesizing and enhancing the bioavailability of nutrients, reducing symptoms of lactose intolerance, decreasing the prevalence of allergy in susceptible individuals, and reducing the risk of certain cancers. In the recent COVID-19 issue, searches are going fast to use probiotics as vaccine carriers, dysbiosis balancer, and immunity booster. The high expectation from probiotics expanded the development of bioengineered probiotics as new-generation probiotics. From the animal model and in vitro studies, the probiotic intervention is extrapolated to innate and adaptive immunity inducer against SARS viral infections. The possibility of using it as prophylactic and therapeutic agents in COVID-19 is explored. However, its significant activity against corona virus-induced respiratory syndromes is questioned by a few researchers also. The emerging citations on the research approach and meta-analysis of probiotic intervention against the re-emerging pandemic viral attack on the respiratory and gastrointestinal domains need to be analyzed in this context. As it is essential to understand the reality of recent experimental outcomes in the probiotic approach towards SARS-CoV-2 prevention, management, and control, the recent publications were focused on this review. |
format | Online Article Text |
id | pubmed-7836964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier B.V. on behalf of King Saud University. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78369642021-01-26 Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review Al-Ansari, Mysoon M. Sahlah, Samer A. AlHumaid, Lateefah Ranjit Singh, A.J. J King Saud Univ Sci Review In recent years increased attention is focussed on microorganisms inhabiting the digestive system that provides prophylactic and therapeutic benefits to the host. After Metchnikoff exposed the secret behind Bulgarian peasants' extended longevity, a graze to incorporate the responsible microbes in functional food emerged. Then interest towards microbe-rich food went to the vegetative phase for some time, but now a renaissance to engage these wonder microbes in the healthcare sector is increasing. With a new definition, probiotics, these good microbes have been widely applied in different types of products, either as pharmaceuticals, nutritional supplements, or foods. Probiotics, a significant source in functional dairy products, claims diverse roles such as improving intestinal tract health, enhancing the immune system, synthesizing and enhancing the bioavailability of nutrients, reducing symptoms of lactose intolerance, decreasing the prevalence of allergy in susceptible individuals, and reducing the risk of certain cancers. In the recent COVID-19 issue, searches are going fast to use probiotics as vaccine carriers, dysbiosis balancer, and immunity booster. The high expectation from probiotics expanded the development of bioengineered probiotics as new-generation probiotics. From the animal model and in vitro studies, the probiotic intervention is extrapolated to innate and adaptive immunity inducer against SARS viral infections. The possibility of using it as prophylactic and therapeutic agents in COVID-19 is explored. However, its significant activity against corona virus-induced respiratory syndromes is questioned by a few researchers also. The emerging citations on the research approach and meta-analysis of probiotic intervention against the re-emerging pandemic viral attack on the respiratory and gastrointestinal domains need to be analyzed in this context. As it is essential to understand the reality of recent experimental outcomes in the probiotic approach towards SARS-CoV-2 prevention, management, and control, the recent publications were focused on this review. The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2021-03 2020-12-16 /pmc/articles/PMC7836964/ /pubmed/33519144 http://dx.doi.org/10.1016/j.jksus.2020.101286 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Al-Ansari, Mysoon M. Sahlah, Samer A. AlHumaid, Lateefah Ranjit Singh, A.J. Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title | Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title_full | Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title_fullStr | Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title_full_unstemmed | Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title_short | Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review |
title_sort | probiotic lactobacilli: can be a remediating supplement for pandemic covid-19. a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836964/ https://www.ncbi.nlm.nih.gov/pubmed/33519144 http://dx.doi.org/10.1016/j.jksus.2020.101286 |
work_keys_str_mv | AT alansarimysoonm probioticlactobacillicanbearemediatingsupplementforpandemiccovid19areview AT sahlahsamera probioticlactobacillicanbearemediatingsupplementforpandemiccovid19areview AT alhumaidlateefah probioticlactobacillicanbearemediatingsupplementforpandemiccovid19areview AT ranjitsinghaj probioticlactobacillicanbearemediatingsupplementforpandemiccovid19areview |